These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1427588)

  • 1. [Diagnosis and treatment of familial hypercholesterolemia].
    Makino I
    Hokkaido Igaku Zasshi; 1992 Jul; 67(4):437-40. PubMed ID: 1427588
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of familial hypercholesterolemia associated with nephrotic syndrome].
    Nakai T; Matsuda T; Takai H; Maeda H; Takahashi S; Oida K; Tamai T; Miyaho S; Morikawa K; Kurota M
    Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):1079-80. PubMed ID: 2121878
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined effects of probucol and cholestyramine in familial type II hyperlipoproteinaemia.
    Pasquali R; Biso P; Parenti M; Melchionda N
    Lancet; 1981 Jun; 1(8234):1368. PubMed ID: 6113336
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of low-dose cholestyramine in long-term therapy of hypercholesterolemia].
    Cattin L; Da Col PG; Fonda M; Mazzone C; Pertot P
    G Clin Med; 1990 Feb; 71(2):99-104. PubMed ID: 2347462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
    Yamamoto K; Fukushima N; Ozaki I; Setoguchi Y; Yanagita T; Sakai T
    Artery; 1991; 18(3):133-49. PubMed ID: 2069518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypercholesterolemia.
    Kane JP; Havel RJ
    Annu Rev Med; 1986; 37():427-35. PubMed ID: 3518611
    [No Abstract]   [Full Text] [Related]  

  • 7. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR
    J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined drug therapy for familial hypercholesterolemia.
    Packard CJ; Stewart JM; Morgan HG; Lorimer AR; Shepherd J
    Artery; 1980; 7(4):281-9. PubMed ID: 7213018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.
    Yamamoto A; Yamamura T; Yokoyama S; Sudo H; Matsuzawa Y
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):493-7. PubMed ID: 6500769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of LDL receptors and response to lovastatin therapy in familial homozygotic hypercholesterolemia].
    Ausina Gómez A; Gilsanz Peral A; Montero Brens C; Dalmau Serra J
    An Esp Pediatr; 1991 Nov; 35(5):327-31. PubMed ID: 1785747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy in children and adolescents with familial hypercholesterolemia.
    Stein EA
    Prog Clin Biol Res; 1988; 255():273-80. PubMed ID: 3340641
    [No Abstract]   [Full Text] [Related]  

  • 12. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
    Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J; Oette K; Burrichter H
    Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate and cholestyramine in type II hyperlipoproteinaemia.
    Lehtonen A; Viikari J
    Artery; 1982; 10(5):353-67. PubMed ID: 7181678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Probucol : comparison of its effect with that of a placebo in hyperlipoproteinemia type II].
    Beaumont V
    Nouv Presse Med; 1980 Oct; 9(40):3011-3. PubMed ID: 7443442
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Hopkins PN; Toth PP; Ballantyne CM; Rader DJ;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S9-17. PubMed ID: 21600530
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
    Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer.
    Kritchevsky SB; Wilcosky TC; Morris DL; Truong KN; Tyroler HA
    Cancer Res; 1991 Jun; 51(12):3198-203. PubMed ID: 2039996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of bezafibrate and of a bezafibrate and cholestyramine combination on lipids and lipoprotein lipids in type IIa hypercholesterolaemic patients.
    Sommariva D; Tirrito M; Bonfiglioli D; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Res; 1986; 6(3):249-53. PubMed ID: 3744628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.